CovidV2, Main, Exploration, bibRecord, 000D16

Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents

Identifieur interne : 000D16 ( Main/Exploration ); précédent : 000D15; suivant : 000D17

Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents

Auteurs : A. Karaküçük- Yido An [Turquie] ; B. Ayd Nöz [Turquie] ; T. Ta K N-Tok [Turquie] ; E. E. Oruç-Emre [Turquie] ; J. Balzarini [Belgique]

Source :

Pharmaceutical Chemistry Journal [ 0091-150X ] ; 2019.

RBID : PMC:7089137

Abstract

Two series of new aromatic thiosemicarbazone derivatives were synthesized by condensation of N-(4-cyanophenyl)hydrazine carbothioamide (I) and N-(4-methylsulfanylphenyl)hydrazine carbothioamide (II) with appropriate aromatic aldehydes in order to investigate their antiviral and cytostatic potency. The chemical structures of all compounds were fully characterized by elemental analysis and spectroscopic techniques. The results of the bioassays indicated that compounds Id, Ie, If and IIf proved inhibitory against influenza virus A (EC₅₀ = 13 – 27 μg/mL for strain H1N1 and 9.3 – 18 μg/mL for strain H3N2). Compounds Ig and IIg were the most cytostatic compounds with inhibition of HeLa cell proliferation at an IC₅₀ = 0.3 μg/mL for Ig and 1.9 μg/mL for IIg. Especially, compound Ig showed the highest cytostatic activity with IC₅₀ of 0.30, 0.70 and 2.50 μg/mL against HeLa, CEM and L1210 cell lines, respectively. This inhibition range was within the same order of magnitude as that for cisplatin. Furthermore, molecular modeling was carried out to examine the cytostatic activity and determine the best pharmacophore model as a guide for the design and development of potential prodrugs in future studies.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089137

DOI: 10.1007/s11094-019-01968-3
PubMed: NONE
PubMed Central: 7089137

Affiliations:

Belgique, Turquie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents</title>
<author><name sortKey="Karakucuk Yido An, A" sort="Karakucuk Yido An, A" uniqKey="Karakucuk Yido An A" first="A." last="Karaküçük- Yido An">A. Karaküçük- Yido An</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ayd Noz, B" sort="Ayd Noz, B" uniqKey="Ayd Noz B" first="B." last="Ayd Nöz">B. Ayd Nöz</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ta K N Tok, T" sort="Ta K N Tok, T" uniqKey="Ta K N Tok T" first="T." last="Ta K N-Tok">T. Ta K N-Tok</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oruc Emre, E E" sort="Oruc Emre, E E" uniqKey="Oruc Emre E" first="E. E." last="Oruç-Emre">E. E. Oruç-Emre</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Balzarini, J" sort="Balzarini, J" uniqKey="Balzarini J" first="J." last="Balzarini">J. Balzarini</name>
<affiliation wicri:level="1"><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id>
<institution-id institution-id-type="GRID">grid.5596.f</institution-id>
<institution>Laboratory of Virology and Chemotherapy,</institution>
<institution>Rega Institute for Medical Research, KU Leuven,</institution>
</institution-wrap>
3000 Leuven, Belgium</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>3000 Leuven</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7089137</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089137</idno>
<idno type="RBID">PMC:7089137</idno>
<idno type="doi">10.1007/s11094-019-01968-3</idno>
<idno type="pmid">NONE</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000317</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000317</idno>
<idno type="wicri:Area/Pmc/Curation">000317</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000317</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000228</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000228</idno>
<idno type="wicri:Area/Ncbi/Merge">001764</idno>
<idno type="wicri:Area/Ncbi/Curation">001764</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001764</idno>
<idno type="wicri:doubleKey">0091-150X:2019:Karakucuk Yido An A:synthesis:biological:evaluation</idno>
<idno type="wicri:Area/Main/Merge">000D18</idno>
<idno type="wicri:Area/Main/Curation">000D16</idno>
<idno type="wicri:Area/Main/Exploration">000D16</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents</title>
<author><name sortKey="Karakucuk Yido An, A" sort="Karakucuk Yido An, A" uniqKey="Karakucuk Yido An A" first="A." last="Karaküçük- Yido An">A. Karaküçük- Yido An</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ayd Noz, B" sort="Ayd Noz, B" uniqKey="Ayd Noz B" first="B." last="Ayd Nöz">B. Ayd Nöz</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ta K N Tok, T" sort="Ta K N Tok, T" uniqKey="Ta K N Tok T" first="T." last="Ta K N-Tok">T. Ta K N-Tok</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oruc Emre, E E" sort="Oruc Emre, E E" uniqKey="Oruc Emre E" first="E. E." last="Oruç-Emre">E. E. Oruç-Emre</name>
<affiliation wicri:level="1"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000107049315</institution-id>
<institution-id institution-id-type="GRID">grid.411549.c</institution-id>
<institution>Department of Chemistry,</institution>
<institution>Gaziantep University,</institution>
</institution-wrap>
27310 Gaziantep, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>27310 Gaziantep</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Balzarini, J" sort="Balzarini, J" uniqKey="Balzarini J" first="J." last="Balzarini">J. Balzarini</name>
<affiliation wicri:level="1"><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id>
<institution-id institution-id-type="GRID">grid.5596.f</institution-id>
<institution>Laboratory of Virology and Chemotherapy,</institution>
<institution>Rega Institute for Medical Research, KU Leuven,</institution>
</institution-wrap>
3000 Leuven, Belgium</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>3000 Leuven</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Pharmaceutical Chemistry Journal</title>
<idno type="ISSN">0091-150X</idno>
<idno type="eISSN">1573-9031</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="Par1">Two series of new aromatic thiosemicarbazone derivatives were synthesized by condensation of <italic>N</italic>
-(4-cyanophenyl)hydrazine carbothioamide (<bold>I</bold>
) and <italic>N</italic>
-(4-methylsulfanylphenyl)hydrazine carbothioamide (<bold>II</bold>
) with appropriate aromatic aldehydes in order to investigate their antiviral and cytostatic potency. The chemical structures of all compounds were fully characterized by elemental analysis and spectroscopic techniques. The results of the bioassays indicated that compounds <bold>Id</bold>
, <bold>Ie</bold>
, <bold>If</bold>
 and <bold>IIf</bold>
 proved inhibitory against influenza virus A (EC<sub>50</sub>
 = 13 – 27 μg/mL for strain H1N1 and 9.3 – 18 μg/mL for strain H3N2). Compounds <bold>Ig</bold>
 and <bold>IIg</bold>
 were the most cytostatic compounds with inhibition of HeLa cell proliferation at an IC<sub>50</sub>
 = 0.3 μg/mL for <bold>Ig</bold>
 and 1.9 μg/mL for <bold>IIg</bold>
. Especially, compound <bold>Ig</bold>
 showed the highest cytostatic activity with IC<sub>50</sub>
 of 0.30, 0.70 and 2.50 μg/mL against HeLa, CEM and L1210 cell lines, respectively. This inhibition range was within the same order of magnitude as that for cisplatin. Furthermore, molecular modeling was carried out to examine the cytostatic activity and determine the best pharmacophore model as a guide for the design and development of potential prodrugs in future studies.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Domagk, G" uniqKey="Domagk G">G Domagk</name>
</author>
<author><name sortKey="Behnisch, R" uniqKey="Behnisch R">R Behnisch</name>
</author>
<author><name sortKey="Mietzsch, F" uniqKey="Mietzsch F">F Mietzsch</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hamre, D" uniqKey="Hamre D">D Hamre</name>
</author>
<author><name sortKey="Bernstein, J" uniqKey="Bernstein J">J Bernstein</name>
</author>
<author><name sortKey="Donovick, R" uniqKey="Donovick R">R Donovick</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bauer, Dj" uniqKey="Bauer D">DJ Bauer</name>
</author>
<author><name sortKey="St Vincent, L" uniqKey="St Vincent L">L St. Vincent</name>
</author>
<author><name sortKey="Kempe, Ch" uniqKey="Kempe C">CH Kempe</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Finch, Ra" uniqKey="Finch R">RA Finch</name>
</author>
<author><name sortKey="Liu, M C" uniqKey="Liu M">M-C Liu</name>
</author>
<author><name sortKey="Grill, Sp" uniqKey="Grill S">SP Grill</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Solomon, Vr" uniqKey="Solomon V">VR Solomon</name>
</author>
<author><name sortKey="Hu, C" uniqKey="Hu C">C Hu</name>
</author>
<author><name sortKey="Lee, H" uniqKey="Lee H">H Lee</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Noll, Dm" uniqKey="Noll D">DM Noll</name>
</author>
<author><name sortKey="Mason, Tm" uniqKey="Mason T">TM Mason</name>
</author>
<author><name sortKey="Miller, Ps" uniqKey="Miller P">PS Miller</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fleming, Ff" uniqKey="Fleming F">FF Fleming</name>
</author>
<author><name sortKey="Yao, L" uniqKey="Yao L">L Yao</name>
</author>
<author><name sortKey="Ravikumar, Pc" uniqKey="Ravikumar P">PC Ravikumar</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Karakucuk Iyido An, A" uniqKey="Karakucuk Iyido An A">A Karaküçük-Iyidoğan</name>
</author>
<author><name sortKey="Ta Demir, D" uniqKey="Ta Demir D">D Taşdemir</name>
</author>
<author><name sortKey="Oruc Emre, Ee" uniqKey="Oruc Emre E">EE Oruç-Emre</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Karakucuk Iyido An, A" uniqKey="Karakucuk Iyido An A">A Karaküçük-Iyidoğan</name>
</author>
<author><name sortKey="Mercan, Z" uniqKey="Mercan Z">Z Mercan</name>
</author>
<author><name sortKey="Oruc Emre, Ee" uniqKey="Oruc Emre E">EE Oruç-Emre</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Huang, H" uniqKey="Huang H">H Huang</name>
</author>
<author><name sortKey="Chen, Q" uniqKey="Chen Q">Q Chen</name>
</author>
<author><name sortKey="Ku, X" uniqKey="Ku X">X Ku</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Leigh, M" uniqKey="Leigh M">M Leigh</name>
</author>
<author><name sortKey="Raines, Dj" uniqKey="Raines D">DJ Raines</name>
</author>
<author><name sortKey="Castillo, Ce" uniqKey="Castillo C">CE Castillo</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Chornous, Va" uniqKey="Chornous V">VA Chornous</name>
</author>
<author><name sortKey="Grozav, An" uniqKey="Grozav A">AN Grozav</name>
</author>
<author><name sortKey="Todoriko, Ld" uniqKey="Todoriko L">LD Todoriko</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Tsoukala, E" uniqKey="Tsoukala E">E Tsoukala</name>
</author>
<author><name sortKey="Tzioumaki, N" uniqKey="Tzioumaki N">N Tzioumaki</name>
</author>
<author><name sortKey="Manta, S" uniqKey="Manta S">S Manta</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list><country><li>Belgique</li>
<li>Turquie</li>
</country>
</list>
<tree><country name="Turquie"><noRegion><name sortKey="Karakucuk Yido An, A" sort="Karakucuk Yido An, A" uniqKey="Karakucuk Yido An A" first="A." last="Karaküçük- Yido An">A. Karaküçük- Yido An</name>
</noRegion>
<name sortKey="Ayd Noz, B" sort="Ayd Noz, B" uniqKey="Ayd Noz B" first="B." last="Ayd Nöz">B. Ayd Nöz</name>
<name sortKey="Oruc Emre, E E" sort="Oruc Emre, E E" uniqKey="Oruc Emre E" first="E. E." last="Oruç-Emre">E. E. Oruç-Emre</name>
<name sortKey="Ta K N Tok, T" sort="Ta K N Tok, T" uniqKey="Ta K N Tok T" first="T." last="Ta K N-Tok">T. Ta K N-Tok</name>
</country>
<country name="Belgique"><noRegion><name sortKey="Balzarini, J" sort="Balzarini, J" uniqKey="Balzarini J" first="J." last="Balzarini">J. Balzarini</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D16 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:7089137
   |texte=   Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021

Serveur d'exploration Covid (26 mars)

Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents

Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration Covid (26 mars)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.